Oxytocin intranasal spray

DRUG2 trials

Sponsors

George Washington University, Dutch Growth Research Foundation Westzeedijk 106, 3016 AH Rotterdam Tel: 010-2251533 info@kindengroei.nl

Conditions

Genetically confirmed diagnosis of Prader-Willi syndromeSleep Apnea, Obstructive

Phase 2

Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep

CompletedNCT03148899

George Washington UniversitySleep Apnea, Obstructive

Start: 2016-07-27End: 2020-06-07Updated: 2023-01-31

Unknown Phase

Intranasal administration of oxytocin in PWS

Active, not recruitingNL-OMON21542

Dutch Growth Research Foundation Westzeedijk 106, 3016 AH Rotterdam Tel: 010-2251533 info@kindengroei.nlGenetically confirmed diagnosis of Prader-Willi syndrome

Start: 2015-01-01Target: 28Updated: 2024-02-28

Related Papers

Intranasal oxytocin increases respiratory rate and reduces obstructive event duration and oxygen desaturation in obstructive sleep apnea patients: a randomized double blinded placebo controlled study.

2020-06-0524 citations